About the Cancer Drugs Market Session
The sales of cancer drugs and related services by entities (organizations, sole traders, and partnerships) that create oncology drugs to diagnose and treat all forms of malignancies constituting the oncology drugs market. This industry comprises manufactures of medications for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain cancer, and other cancers with chemotherapy, surgery, and radiotherapy. Drugs are developed by the pharmaceutical industry to diagnose, cure, or prevent diseases. Since 2015, the worldwide oncology drugs market has grown at a compound annual growth rate (CAGR) of 9.8%, reaching over $167.9 billion in 2019. At a CAGR of 9.7%, the market is predicted to rise modestly from $201.1 billion in 2021 to $284.5 billion in 2023. The market is predicted to level out in 2025, reaching $284.5 billion and $412.9 billion by 2030.
- Strong pipeline of drugs
- Drug market: current and expected trends
- Oncology market during pandemic
- FDA rules and regulations
Topics Covered in Cancer Drugs Market
Oncology Drug Pipeline
Biosimilars & Generics
Drug Pricing & Access
Reimbursement Models
Targeted Therapy Demand
Regulatory Approvals
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Drugs Market Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Drugs Market work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Drugs Market research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Drugs Market track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Drugs Market Conference 2027 — FAQs
What is the Cancer Drugs Market track at CIOC 2027?
The Cancer Drugs Market track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Drugs Market. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Drugs Market sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Drugs Market are all welcome — whether presenting or attending.
Can I present my research in the Cancer Drugs Market track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Drugs Market sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Drugs Market track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.